Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-009869
Filing Date
2025-03-04
Accepted
2025-03-04 16:20:01
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741123193.html 4  
1 FORM 4 wk-form4_1741123193.xml 4 6888
  Complete submission text file 0001628280-25-009869.txt   8436
Mailing Address C/O OPGEN, INC. 708 QUINCE ORCHARD ROAD, SUITE 205 GAITHERSBURG MD 20878
Business Address
DEC TIMOTHY C (Reporting) CIK: 0001194020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 25704768

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)